Αρχική World News France Bans all Textured and Polyurethane Breast Implants Amid BIA-ALCL Cancer Scare

France Bans all Textured and Polyurethane Breast Implants Amid BIA-ALCL Cancer Scare

Breast implants have been a highly debated topic in the last several months, as an increasing number of cases of a rare cancer have been found in women with breast implants, most often textured ones. There have been upwards of 600 cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) worldwide and at least 457 cases in the U.S. alone. At least 16 women worldwide have died of the disease, nine of which were in the U.S.In November of 2018, when the Implant Files Investigation led by the International Consortium of Investigative Journalists was published and brought many of these cases to light, it sparked a global concern about the safety of breast implants. Since then, French regulatory officials asked breast implant manufacturer Allergan to recall its textured implants in the 33 countries where it sold them. At the time, Allergan’s textured implants made up 85 percent of the French breast implant market.Now the country is taking an even larger step for women’s safety—banning all textured and polyurethane breast implants.Photo: Adobe Stock/Pranav
Six manufacturers, namely Allergan (for its Biocell implants), Arion, Sebbin, Nagor, Eurosilicone, and Polytech, are targeted by the ban and will no longer be able to sell their macro-textured and polyurethane breast implant products in France, starting April 5th, 2019.BIA-ALCL is a rare type of cancer of the immune system which originates and causes symptoms in the tissue area surrounding the breast implant. Of the roughly 500,000 women in France who have gotten breast implants, only 59 women have developed the disease, and just three women have died of BIA-ALCL.Because the risk of developing BIA-ALCL is very low, it’s important to note that France is only banning the sale and insertion of these implants from here on out as a precautionary measure. Officials are not suggesting that women who already have these implants get them removed.However, women who are experiencing any of the symptoms of BIA-ALCL should see a doctor about it and potentially have their implants removed. Symptoms may include pain, lumps, swelling, breast asymmetry, and other breast changes.
Photo: Adobe Stock/Andrey PopovSo far, the United States does not appear to be getting any closer to banning textured implants or requiring a recall of any such products. The prevalence of textured implants in the states is much lower than in some other countries, at just 13 percent of breast implants.“Many studies have looked to estimate risk and, depending on the source data and country, the global lifetime risk of developing breast-implant-associated ALCL for patients with textured breast implants ranges anywhere from 1 in 3,817 to 1 in 30,000,” the FDA said. The organization also recently sent out letters to primary care physicians encouraging them to become more educated on BIA-ALCL and talk to their patients about it.
Photo: Adobe Stock/New AfricaHowever, you should still consider consulting your doctor if you have any type of breast implant and are exhibiting one or more of the symptoms of BIA-ALCL. Although the cancer is very rare, even in those with textured implants, it can develop in women with smooth implants as well.Luckily, BIA-ALCL is highly treatable. In most cases, simply removing the implants and the surrounding pocket of scar tissue where the cancer resides will cause the issue to clear up on its own. Only in very few cases has the cancer gone undetected long enough to become deadly.Will the U.S. be the next country to ban textured implants? Only time will tell.
Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

ESMO 2020: New Treatments for Advanced Kidney Cancer, Prostate Cancer, and Bladder Cancer

The 2020 European Society for Medical Oncology (ESMO) Virtual Congress was held online from September 19 to September 21. In this podcast, Neeraj Agarwal,...

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn, the chancellor Rishi Sunak will go to Parliament and set out the UK Government’s spending priorities in the Comprehensive Spending Review...

FDA Extends Approval of Pembrolizumab for Classical Hodgkin Lymphoma

On 14 October 2020, the US Food and Drug Administration (FDA) extended the approval of pembrolizumab (KEYTRUDA®, Merck Sharp & Dohme Corp.) for the...

31-Year-Old Mother Dies of Cancer After Her Chemotherapy Was Paused During the Pandemic

The COVID-19 pandemic has been a scary and difficult thing for most of the world, and it’s important to keep safety protocols in place...

For Esophageal Cancer, Immunotherapy Likely to Play Larger Role

October 19, 2020, by NCI Staff An esophagram using barium contrast shows the esophagus. Credit: iStock Immunotherapy may become part of early treatment for some people with...

Targeted Therapy Based on Molecular Profiling of Malignant Mesothelioma Tumours Is Feasible

Targeted therapy recommendations can be made based on the molecular profiles of tumour samples from patients with metastatic malignant mesothelioma (MM) according to findings...